Searchable abstracts of presentations at key conferences in endocrinology

ea0090ep563 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Finerenone reduces Albuminuria in a non-diabetic female with congenital lipodystrophy

Almudhammed Rana

Introduction: Chronic Kidney disease is one of the leading causes of morbidity and mortality worldwide especially among people with diabetes. Finerenone is non-steroidal emerging mineralocorticoid receptor Finerenone has proved to reduce albuminuria and delay the progression of CKD and reduce the cardiovascular risk in non-diabetic population. It is not known whether finerenone has the same effect in non-diabetic CKD. I used finerenone in a case of microalbuminuria in a female...

ea0090ep936 | Reproductive and Developmental Endocrinology | ECE2023

Treatment Challenges of a virilized female with 46 XX CAH diagnosed at the age of 13

Almudhammed Rana

Introduction: DSD is a group of disorders by which there is discrepancy between genomic sex and phenotypical sex. Most of cases of DSD are picked up during neonatal period due to ambiguous genitalia. Few cases are diagnosed in adolescence or even at puberty due to various causes like mild ambiguity, complete phenotype sex reversal, lack of breast development and primary amenorrhea, we review a case of 46XX CAH girl due to CYP21 hydroxylase deficiency which was diagnosed late a...

ea0063ep99 | Pituitary and Neuroendocrinology | ECE2019

Challenges in management of diabetes insipidus with impaired thirst perception

Siddique Rana , Tauni Rahat

A 37-year-old female, referred by gynaecologist with low prolactin and free T4 after work up for secondary amenorrhea despite removal of contraceptive coil 18 months ago. Her only daughter was born seven years ago with no complications. Patient admitted to have tiredness and dizziness for a few years but denied headache or visual symptoms. Pituitary hormone profile confirmed secondary hypothyroidism, secondary hypogonadism, low prolactin, low IGF-1 level but normal adrenal axi...

ea0033p56 | (1) | BSPED2013

Review of the service for Turner syndrome patients at University Hospital of North Staffordshire

Zoualghina Rana , Kumbattae Umma

Management of children with Turner’s syndrome in the Paediatric Endocrine Service in the last 15 years were reviewed retrospectively. There were 19 children with age range from 2 to 16 years.The age distribution at diagnosis showed 12/19(63%) diagnosed below 1-year-old of those 5/12 (42%) were diagnosed by amniocentesis. 4/19 were diagnosed between 1 and 5 years old, only 3/19 came to medical attention after 10 years of age. Two were mosaic karyotyp...

ea0073aep67 | Adrenal and Cardiovascular Endocrinology | ECE2021

Diagnosing Cushing’s syndrome due to Ectopic ACTH secretion warrants high Index of Suspicion- phenotypical features may not always present

Siddique Rana , Brahma Anupam

Patients with Cushing’s syndrome usually have characteristic phenotypical features but this is not always true in case of Ectopic ACTH secretion. This is mainly because this develops more acutely and underlying malignancy can cause significant weight loss. We report a 71 years old male with background of Prostatic malignancy who was found to have new profound hypokalaemia which was resistant to treatment. There were no signs of Cushing’s syndrome but index of suspici...

ea0065p240 | Metabolism and Obesity | SFEBES2019

Safe use of variable rate intravenous insulin infusion: a trust wide audit

Siddique Rana , Tauni Rahat Ali

Aims and objectives: Variable rate insulin infusion (VRII) is commonly used to achieve normoglycaemia in hospitalised patients. Joint British Diabetes Society (JBDS) produced guidelines on VRIII in 2014 to minimise complications related to inpatient VRII use. Local guidance along with a new VRII chart was introduced in 2017 at the West Suffolk NHS Foundation Trust and staff training provided. We performed an audit to review compliance to national and local VRII guidance.<p...

ea0065p435 | Thyroid | SFEBES2019

Early diagnosis and prompt treatment of severe thyrotoxicosis in patients with congestive cardiac failure is critical: lessons from a case of type 1 amiodarone induced severe thyrotoxicosis

Siddique Rana , Ai Tauni Rahat

Cardiac failure is a rare manifestation of thyrotoxicosis in patients without heart disease. However, patients with prior cardiac failure are at high risk of decompensation with thyrotoxicosis. Amiodarone is a widely used antiarrhythmic agent and amiodarone induced thyrotoxicosis (AIT) is not an uncommon complication. We present a case. A 48-year old male with intermittent atrial flutter, dilated cardiomyopathy, myocardial infarction and stroke was referred for severe thyrotox...

ea0049ep360 | Cardiovascular Endocrinology and Lipid Metabolism | ECE2017

Awareness and prevalence of metabolic syndrome among high-risk individuals attending internal medicine clinics across Jordan

Efaishat Rania , Farha Rana Abu , Alefishat Eman

Purpose: To examine the prevalence and awareness of metabolic syndrome (MetS) in high-risk individuals attending 30 internal medicine clinics in Amman, Jordan, and also to evaluate the various factors associated with increased risk of MetS among them.Methods: This retrospective cross-sectional study was carried out across Amman, Jordan from October to December 2014. During the study period, 900 high-risk individuals (with hypertension, diabetes, central ...

ea0037ep341 | Diabetes (pathiophysiology &amp; epitemiology) | ECE2015

Discrepancies between the glycosylated haemoglobin based criteria and glucose based criteria for diagnosis of diabetes and pre-diabetes

Sharma Sujan , Rana Magar Siddha Bahadur

Objectives: The number of people with diabetes is increasing globally; hence necessitate identifying diabetes earlier and more efficiently. Recently, American Diabetes Association (ADA) recommended the use of glycated haemoglobin (HbA1c) as an alternative to glucose based criteria for diagnosing type 2 diabetes and pre-diabetes. Hence, we aimed to evaluate the discrepancies between HbA1c- and glucose-based criteria for diagnosis of diabetes and pre-diabetes in Nepalese populat...

ea0028p81 | Clinical practice/governance and case reports | SFEBES2012

Proton Pump Inhibitor (PPI) induced severe symptomatic Hypomagnesaemic Hypoparathyroidism

Rana Subhash , Bangar Vijay , Mousa Abdusalam

We report a case who presented with severe symptomatic hypocalcaemia secondary to Hypomagnesaemic Hypoparathyroidism associated with use of PPI. A fifty-seven years male smoker presented with pins and needles in arms and legs for two months with intermittent attacks of his hand becoming locked and stiff (carpopedal spasm) and calf spasms. He was on long term Omeprazole for Barrett’s oesophagus. He had positive Chvostek’s and Trousseau’s sign. Investigations reve...